+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiac Prosthetic Devices Market - Global Forecast 2026-2032- Product Image
Cardiac Prosthetic Devices Market - Global Forecast 2026-2032- Product Image
Sale

Cardiac Prosthetic Devices Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011202
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cardiac Prosthetic Devices Market is projected to reach USD 13.42 Billion in 2026. It is expected to continue growing at a CAGR of 16.26%, reaching USD 33.24 Billion by 2032.

Cardiac prosthetic devices are central to modern structural heart and advanced heart failure care, spanning mechanical heart valves, bioprosthetic valves, transcatheter aortic valve replacement devices, annuloplasty rings, occluders, grafts, and circulatory support technologies. Demand is anchored by the global burden of cardiovascular disease, which the World Health Organization identifies as the leading cause of death worldwide, and by aging populations that are more likely to develop aortic stenosis, mitral regurgitation, heart failure, and other conditions requiring device-based intervention.

The market is increasingly shaped by minimally invasive cardiac surgery, transcatheter valve therapies, improved biomaterials, and stronger evidence from registries and randomized clinical trials. Hospitals, cardiac centers, and ambulatory specialty programs are prioritizing devices that reduce procedural risk, shorten length of stay, and support durable outcomes. For manufacturers and investors, the strongest opportunities sit at the intersection of clinical efficacy, reimbursement access, regulatory compliance, supply chain resilience, and surgeon or interventional cardiologist adoption.

Transformative Shifts in the Cardiac Prosthetic Devices Landscape

The cardiac prosthetic devices landscape is shifting from open surgical replacement toward catheter-based and hybrid procedures. Transcatheter aortic valve replacement has moved from high-risk patients into broader risk categories in many regulated markets, supported by clinical evidence, real-world registries, and guideline adoption. This transition is expanding treatment eligibility for elderly and frail patients while intensifying competition around valve durability, delivery system profile, imaging compatibility, and post-procedure outcomes.

Materials innovation is also transforming the sector. Anti-calcification tissue treatment, polymer valves, refined pyrolytic carbon components, and advanced coatings are being developed to improve durability, hemocompatibility, and resistance to thrombosis or structural valve deterioration. At the same time, value-based procurement is pushing companies to demonstrate not only device performance but also total cost-of-care benefits, including fewer readmissions, lower complication rates, and predictable procedural workflows.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative enabler across the cardiac prosthetic devices value chain. In pre-procedure planning, AI-assisted echocardiography, CT analysis, and 3D segmentation help clinicians evaluate annular dimensions, calcification patterns, vascular access, and prosthesis sizing. These capabilities are particularly relevant for transcatheter valve replacement, paravalvular leak risk assessment, and patient selection in complex structural heart disease.

AI is also improving manufacturing quality, post-market surveillance, and clinical workflow. Machine learning models can support defect detection, predictive maintenance in production environments, real-world evidence analysis, and early identification of adverse event signals. The most commercially relevant AI applications are those integrated into regulated clinical pathways, validated with diverse datasets, and aligned with data privacy requirements such as HIPAA in the United States and GDPR in Europe.

Key Regional Insights

North America remains a leading region for cardiac prosthetic devices because of high cardiovascular procedure volumes, advanced hospital infrastructure, established reimbursement pathways, and early adoption of structural heart innovations. The United States drives much of the regional momentum through FDA-reviewed transcatheter heart valve technologies, strong clinical trial networks, and extensive use of real-world registries, while Canada contributes through universal health coverage, centralized purchasing processes, and growing demand for minimally invasive valve interventions.

Europe continues to be a major market supported by experienced cardiac surgery programs, strong guideline-based care, and adoption of transcatheter valve therapies across Germany, France, Italy, Spain, and the United Kingdom. The European Union Medical Device Regulation has increased the evidence and compliance burden for manufacturers, but it has also elevated the importance of clinical documentation, post-market clinical follow-up, and device traceability. Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN healthcare systems invest in structural heart programs, domestic manufacturing, and broader access to specialist cardiac care.

Latin America, the Middle East, and Africa present mixed but important growth pathways. Brazil and Mexico are key Latin American markets, with demand tied to public-private hospital capacity and import-dependent device access. GCC countries in the Middle East are investing in tertiary cardiac centers and medical technology procurement, while broader African adoption is constrained by affordability, limited specialist infrastructure, and uneven access to cardiac surgery. Across these regions, growth depends on reimbursement design, physician training, local distribution strength, and partnerships that expand access without compromising quality.

Key Group Insights

ASEAN is becoming more relevant for cardiac prosthetic devices as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines expand cardiovascular care capacity. Singapore functions as a regional hub for specialized structural heart procedures, clinical training, and medical technology commercialization, while larger ASEAN markets offer long-term procedural potential as insurance coverage, hospital investment, and specialist availability improve.

The GCC is characterized by high healthcare spending per capita, modernization of tertiary hospitals, and a strong preference for advanced imported medical devices. Saudi Arabia, the United Arab Emirates, Qatar, and other GCC markets are prioritizing cardiovascular centers of excellence, which supports adoption of transcatheter valves, surgical prosthetic valves, and advanced heart failure technologies. In the European Union, regulatory harmonization under MDR creates a structured but demanding environment, rewarding manufacturers with robust clinical evidence, quality systems, and post-market surveillance capabilities.

BRICS economies offer scale and strategic manufacturing opportunities, especially in China, India, and Brazil, where cardiovascular disease burden is high and local production policies influence procurement. G7 markets remain innovation leaders because of mature reimbursement, clinical research depth, and early uptake of premium technologies. NATO countries overlap significantly with high-income North American and European markets, where supply chain security, cybersecurity for connected systems, and resilient access to critical medical devices have become more prominent policy priorities.

Key Country Insights

The United States is the largest single-country opportunity for many cardiac prosthetic device manufacturers due to advanced structural heart programs, FDA regulatory pathways, Medicare coverage mechanisms, and high procedural adoption. Canada offers stable demand through publicly funded care, while Mexico combines private hospital growth with public sector access challenges. Brazil is Latin America's most significant market, supported by large patient volumes and established cardiac surgery expertise, though reimbursement variability and import costs influence adoption.

In Europe, the United Kingdom, Germany, France, Italy, and Spain each maintain strong cardiac care ecosystems, but purchasing dynamics differ by national health system, tendering models, and hospital budgets. Germany is notable for procedural capacity and specialized centers, France and the United Kingdom emphasize health technology assessment and evidence-based reimbursement, and Italy and Spain show continued demand for both surgical and transcatheter solutions. Russia has domestic capacity and cardiovascular demand, but market access can be affected by sanctions, procurement restrictions, currency volatility, and localization policies.

China is scaling structural heart care through hospital investment, regulatory reform, and domestic device innovation, while India offers substantial long-term demand driven by population size, rising diagnosis, and expanding private cardiac networks. Japan is a high-value market with rigorous regulatory expectations, advanced clinical adoption, and a large aging population. Australia supports premium technology uptake through specialized centers and reimbursement systems, and South Korea combines strong hospital infrastructure, medical technology innovation, and growing use of minimally invasive cardiac procedures.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated clinical evidence, not only device features. Randomized trials, post-market registries, and real-world evidence should demonstrate durability, hemodynamic performance, lower complication rates, and economic value. Companies that connect clinical outcomes with hospital workflow benefits will be better positioned in value-based procurement environments.

Manufacturers should also invest in physician training, imaging integration, AI-enabled planning tools, and region-specific access models. In high-income markets, success depends on premium innovation, regulatory excellence, and lifecycle management. In emerging markets, companies should align pricing, financing, distribution, and local partnerships with public health priorities. Supply chain resilience, cybersecurity, quality transparency, and proactive regulatory surveillance should be treated as board-level priorities.

Research Methodology

This executive summary is developed using a structured research methodology that combines secondary research, primary market validation, and analytical triangulation. Secondary inputs include regulatory databases, public health sources, clinical guidelines, peer-reviewed literature, patent activity, hospital procurement trends, and medical device adverse event reporting systems. Particular attention is given to evidence from organizations such as the World Health Organization, national regulators, professional cardiology societies, and recognized clinical trial registries.

Primary validation focuses on perspectives from manufacturers, distributors, clinicians, hospital procurement teams, reimbursement specialists, and regional market experts. Findings are assessed through triangulation across clinical adoption, regulatory status, reimbursement environment, installed care infrastructure, and competitive positioning. This approach supports an evidence-based view of demand drivers, barriers, regional differences, and strategic opportunities in cardiac prosthetic devices.

Conclusion

The cardiac prosthetic devices market is entering a more evidence-intensive and technology-driven phase. Aging populations, cardiovascular disease prevalence, transcatheter innovation, advanced biomaterials, and AI-enabled planning are collectively reshaping how cardiac valve disease and related structural heart conditions are treated. Demand is no longer defined only by surgical replacement volumes; it is increasingly shaped by minimally invasive access, lifecycle outcomes, and integrated care pathways.

Future leadership will depend on the ability to combine durable device performance with regulatory discipline, real-world evidence, affordability, and regional execution. Companies that address unmet clinical needs while supporting physicians, payers, and hospitals with measurable value are best positioned to capture sustainable growth in the global cardiac prosthetic devices industry.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cardiac Prosthetic Devices Market, by Product Type
7.1. Introduction
7.2. Heart Valves
7.3. Left Ventricular Assist Devices
7.3.1. Durable Ventricular Assist Devices
7.3.2. Temporary Ventricular Assist Devices
7.4. Pacemakers
7.4.1. Implantable Pacemakers
7.4.1.1. Single Chamber Pacemakers
7.4.1.2. Dual Chamber Pacemakers
7.4.1.3. Triple Chamber Pacemakers
7.4.2. External Pacemakers
7.5. Implantable Cardioverter Defibrillators
7.6. Ventricular Assist Devices
8. Cardiac Prosthetic Devices Market, by Procedure Type
8.1. Introduction
8.2. Surgical Procedures
8.2.1. Open Heart Surgery
8.2.2. Minimally Invasive Surgery
8.3. Transcatheter Procedures
8.3.1. Transcatheter Aortic Valve Replacement
8.3.2. Transcatheter Mitral Valve Replacement
9. Cardiac Prosthetic Devices Market, by Material Type
9.1. Introduction
9.2. Biological Materials
9.2.1. Bovine Tissue
9.2.2. Porcine Tissue
9.3. Synthetic Materials
9.3.1. Polymers
9.3.2. Pyrolytic Carbon
9.3.3. Metals
10. Cardiac Prosthetic Devices Market, by Indication
10.1. Introduction
10.2. Valvular Heart Diseases
10.2.1. Aortic Stenosis
10.2.2. Mitral Regurgitation
10.2.3. Pulmonary Valve Disease
10.3. Cardiac Arrhythmias
10.3.1. Bradycardia
10.3.2. Tachycardia
10.3.3. Atrial Fibrillation
10.4. Heart Failure
10.5. Cardiomyopathy
11. Cardiac Prosthetic Devices Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Cardiac Centers
11.4. Hospitals
12. Cardiac Prosthetic Devices Market, by Distribution Channel
12.1. Introduction
12.2. Online
12.3. Offline
13. Cardiac Prosthetic Devices Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Cardiac Prosthetic Devices Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Cardiac Prosthetic Devices Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. 4C Medical Technologies, Inc.
17.2. Abbott Laboratories
17.3. Artivion, Inc.
17.4. AtriCure, Inc.
17.5. Berlin Heart GmbH
17.6. BIOTRONIK SE & Co. KG
17.7. Boston Scientific Corporation
17.8. Braile Biomedica
17.9. Colibri Heart Valve, LLC
17.10. Corcym S.r.l.
17.11. Edwards Lifesciences Corporation
17.12. Getinge AB
17.13. JenaValve Technology, Inc.
17.14. Labcor Laboratórios Ltda.
17.15. Lepu Medical Technology (Beijing) Co., Ltd.
17.16. LivaNova PLC
17.17. Medtronic plc
17.18. Meril Life Sciences Pvt. Ltd.
17.19. MicroPort Scientific Corporation
17.20. Shree Pacetronix Ltd.
17.21. SynCardia Systems, LLC
17.22. Terumo Corporation
17.23. TTK Healthcare Ltd.
17.24. Venus Medtech (Hangzhou) Inc.
17.25. W. L. Gore & Associates, Inc.
18. Key Experts
List of Figures
FIGURE 1. Global Cardiac Prosthetic Devices Market, Years Considered for the Study
FIGURE 2. Global Cardiac Prosthetic Devices Market, Research Design
FIGURE 3. Global Cardiac Prosthetic Devices Market, Research Framework
FIGURE 4. Global Cardiac Prosthetic Devices Market, Data Triangulation
FIGURE 5. Global Cardiac Prosthetic Devices Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Cardiac Prosthetic Devices Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Cardiac Prosthetic Devices Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Cardiac Prosthetic Devices Market Size, by Procedure Type, 2025 vs 2032 (%)
FIGURE 9. Global Cardiac Prosthetic Devices Market Size, by Procedure Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Cardiac Prosthetic Devices Market Size, by Material Type, 2025 vs 2032 (%)
FIGURE 11. Global Cardiac Prosthetic Devices Market Size, by Material Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Cardiac Prosthetic Devices Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 13. Global Cardiac Prosthetic Devices Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Cardiac Prosthetic Devices Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Cardiac Prosthetic Devices Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Cardiac Prosthetic Devices Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global Cardiac Prosthetic Devices Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Cardiac Prosthetic Devices Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Cardiac Prosthetic Devices Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Cardiac Prosthetic Devices Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Cardiac Prosthetic Devices Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Cardiac Prosthetic Devices Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Cardiac Prosthetic Devices Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Cardiac Prosthetic Devices Market Segmentation & Coverage
TABLE 2. Global Cardiac Prosthetic Devices Market Size, 2017-2032 (USD Million)
TABLE 3. Global Cardiac Prosthetic Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Heart Valves Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Heart Valves Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Heart Valves Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Left Ventricular Assist Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Left Ventricular Assist Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Left Ventricular Assist Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Durable Ventricular Assist Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Durable Ventricular Assist Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Durable Ventricular Assist Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Temporary Ventricular Assist Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Temporary Ventricular Assist Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Temporary Ventricular Assist Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Pacemakers Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Pacemakers Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Pacemakers Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Implantable Pacemakers Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Implantable Pacemakers Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Implantable Pacemakers Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Single Chamber Pacemakers Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Single Chamber Pacemakers Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Single Chamber Pacemakers Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Dual Chamber Pacemakers Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Dual Chamber Pacemakers Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Dual Chamber Pacemakers Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Triple Chamber Pacemakers Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Triple Chamber Pacemakers Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Triple Chamber Pacemakers Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global External Pacemakers Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global External Pacemakers Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global External Pacemakers Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Implantable Cardioverter Defibrillators Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Implantable Cardioverter Defibrillators Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Implantable Cardioverter Defibrillators Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Ventricular Assist Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Ventricular Assist Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Ventricular Assist Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Cardiac Prosthetic Devices Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 41. Global Surgical Procedures Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Surgical Procedures Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Surgical Procedures Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Open Heart Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Open Heart Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Open Heart Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Minimally Invasive Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Minimally Invasive Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Minimally Invasive Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Transcatheter Procedures Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Transcatheter Procedures Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Transcatheter Procedures Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Transcatheter Aortic Valve Replacement Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Transcatheter Aortic Valve Replacement Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Transcatheter Aortic Valve Replacement Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Transcatheter Mitral Valve Replacement Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Transcatheter Mitral Valve Replacement Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Transcatheter Mitral Valve Replacement Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Cardiac Prosthetic Devices Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 60. Global Biological Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Biological Materials Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Biological Materials Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Bovine Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Bovine Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Bovine Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Porcine Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Porcine Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Porcine Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Synthetic Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Synthetic Materials Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Synthetic Materials Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Polymers Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Polymers Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Polymers Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Pyrolytic Carbon Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Pyrolytic Carbon Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Pyrolytic Carbon Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Metals Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Metals Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Metals Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Cardiac Prosthetic Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 82. Global Valvular Heart Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Valvular Heart Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Valvular Heart Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Aortic Stenosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Aortic Stenosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Aortic Stenosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Mitral Regurgitation Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Mitral Regurgitation Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Mitral Regurgitation Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Pulmonary Valve Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Pulmonary Valve Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Pulmonary Valve Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Cardiac Arrhythmias Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Cardiac Arrhythmias Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Cardiac Arrhythmias Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Bradycardia Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Bradycardia Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Bradycardia Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Tachycardia Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Tachycardia Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Tachycardia Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Atrial Fibrillation Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Atrial Fibrillation Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Atrial Fibrillation Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Heart Failure Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Heart Failure Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Heart Failure Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Cardiomyopathy Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Cardiomyopathy Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Cardiomyopathy Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Cardiac Prosthetic Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Cardiac Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Cardiac Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Cardiac Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Cardiac Prosthetic Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Cardiac Prosthetic Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Cardiac Prosthetic Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Cardiac Prosthetic Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Cardiac Prosthetic Devices Market Size, by Left Ventricular Assist Devices, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Cardiac Prosthetic Devices Market Size, by Pacemakers, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Cardiac Prosthetic Devices Market Size, by Implantable Pacemakers, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Cardiac Prosthetic Devices Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Cardiac Prosthetic Devices Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Cardiac Prosthetic Devices Market Size, by Transcatheter Procedures, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Cardiac Prosthetic Devices Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Cardiac Prosthetic Devices Market Size, by Biological Materials, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Cardiac Prosthetic Devices Market Size, by Synthetic Materials, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific Cardiac Prosthetic Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific Cardiac Prosthetic Devices Market Size, by Valvular Heart Diseases, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific Cardiac Prosthetic Devices Market Size, by Cardiac Arrhythmias, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Cardiac Prosthetic Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Cardiac Prosthetic Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. North America Cardiac Prosthetic Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. North America Cardiac Prosthetic Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. North America Cardiac Prosthetic Devices Market Size, by Left Ventricular Assist Devices, 2017-2032 (USD Million)
TABLE 149. North America Cardiac Prosthetic Devices Market Size, by Pacemakers, 2017-2032 (USD Million)
TABLE 150. North America Cardiac Prosthetic Devices Market Size, by Implantable Pacemakers, 2017-2032 (USD Million)
TABLE 151. North America Cardiac Prosthetic Devices Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 152. North America Cardiac Prosthetic Devices Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 153. North America Cardiac Prosthetic Devices Market Size, by Transcatheter Procedures, 2017-2032 (USD Million)
TABLE 154. North America Cardiac Prosthetic Devices Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 155. North America Cardiac Prosthetic Devices Market Size, by Biological Materials, 2017-2032 (USD Million)
TABLE 156. North America Cardiac Prosthetic Devices Market Size, by Synthetic Materials, 2017-2032 (USD Million)
TABLE 157. North America Cardiac Prosthetic Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 158. North America Cardiac Prosthetic Devices Market Size, by Valvular Heart Diseases, 2017-2032 (USD Million)
TABLE 159. North America Cardiac Prosthetic Devices Market Size, by Cardiac Arrhythmias, 2017-2032 (USD Million)
TABLE 160. North America Cardiac Prosthetic Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. North America Cardiac Prosthetic Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. Latin America Cardiac Prosthetic Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Latin America Cardiac Prosthetic Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 164. Latin America Cardiac Prosthetic Devices Market Size, by Left Ventricular Assist Devices, 2017-2032 (USD Million)
TABLE 165. Latin America Cardiac Prosthetic Devices Market Size, by Pacemakers, 2017-2032 (USD Million)
TABLE 166. Latin America Cardiac Prosthetic Devices Market Size, by Implantable Pacemakers, 2017-2032 (USD Million)
TABLE 167. Latin America Cardiac Prosthetic Devices Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 168. Latin America Cardiac Prosthetic Devices Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 169. Latin America Cardiac Prosthetic Devices Market Size, by Transcatheter Procedures, 2017-2032 (USD Million)
TABLE 170. Latin America Cardiac Prosthetic Devices Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 171. Latin America Cardiac Prosthetic Devices Market Size, by Biological Materials, 2017-2032 (USD Million)
TABLE 172. Latin America Cardiac Prosthetic Devices Market Size, by Synthetic Materials, 2017-2032 (USD Million)
TABLE 173. Latin America Cardiac Prosthetic Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 174. Latin America Cardiac Prosthetic Devices Market Size, by Valvular Heart Diseases, 2017-2032 (USD Million)
TABLE 175. Latin America Cardiac Prosthetic Devices Market Size, by Cardiac Arrhythmias, 2017-2032 (USD Million)
TABLE 176. Latin America Cardiac Prosthetic Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Latin America Cardiac Prosthetic Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. Europe Cardiac Prosthetic Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Europe Cardiac Prosthetic Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 180. Europe Cardiac Prosthetic Devices Market Size, by Left Ventricular Assist Devices, 2017-2032 (USD Million)
TABLE 181. Europe Cardiac Prosthetic Devices Market Size, by Pacemakers, 2017-2032 (USD Million)
TABLE 182. Europe Cardiac Prosthetic Devices Market Size, by Implantable Pacemakers, 2017-2032 (USD Million)
TABLE 183. Europe Cardiac Prosthetic Devices Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 184. Europe Cardiac Prosthetic Devices Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 185. Europe Cardiac Prosthetic Devices Market Size, by Transcatheter Procedures, 2017-2032 (USD Million)
TABLE 186. Europe Cardiac Prosthetic Devices Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 187. Europe Cardiac Prosthetic Devices Market Size, by Biological Materials, 2017-2032 (USD Million)
TABLE 188. Europe Cardiac Prosthetic Devices Market Size, by Synthetic Materials, 2017-2032 (USD Million)
TABLE 189. Europe Cardiac Prosthetic Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 190. Europe Cardiac Prosthetic Devices Market Size, by Valvular Heart Diseases, 2017-2032 (USD Million)
TABLE 191. Europe Cardiac Prosthetic Devices Market Size, by Cardiac Arrhythmias, 2017-2032 (USD Million)
TABLE 192. Europe Cardiac Prosthetic Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Europe Cardiac Prosthetic Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. Middle East Cardiac Prosthetic Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 195. Middle East Cardiac Prosthetic Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 196. Middle East Cardiac Prosthetic Devices Market Size, by Left Ventricular Assist Devices, 2017-2032 (USD Million)
TABLE 197. Middle East Cardiac Prosthetic Devices Market Size, by Pacemakers, 2017-2032 (USD Million)
TABLE 198. Middle East Cardiac Prosthetic Devices Market Size, by Implantable Pacemakers, 2017-2032 (USD Million)
TABLE 199. Middle East Cardiac Prosthetic Devices Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 200. Middle East Cardiac Prosthetic Devices Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 201. Middle East Cardiac Prosthetic Devices Market Size, by Transcatheter Procedures, 2017-2032 (USD Million)
TABLE 202. Middle East Cardiac Prosthetic Devices Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 203. Middle East Cardiac Prosthetic Devices Market Size, by Biological Materials, 2017-2032 (USD Million)
TABLE 204. Middle East Cardiac Prosthetic Devices Market Size, by Synthetic Materials, 2017-2032 (USD Million)
TABLE 205. Middle East Cardiac Prosthetic Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 206. Middle East Cardiac Prosthetic Devices Market Size, by Valvular Heart Diseases, 2017-2032 (USD Million)
TABLE 207. Middle East Cardiac Prosthetic Devices Market Size, by Cardiac Arrhythmias, 2017-2032 (USD Million)
TABLE 208. Middle East Cardiac Prosthetic Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Middle East Cardiac Prosthetic Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 210. Africa Cardiac Prosthetic Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 211. Africa Cardiac Prosthetic Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. Africa Cardiac Prosthetic Devices Market Size, by Left Ventricular Assist Devices, 2017-2032 (USD Million)
TABLE 213. Africa Cardiac Prosthetic Devices Market Size, by Pacemakers, 2017-2032 (USD Million)
TABLE 214. Africa Cardiac Prosthetic Devices Market Size, by Implantable Pacemakers, 2017-2032 (USD Million)
TABLE 215. Africa Cardiac Prosthetic Devices Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 216. Africa Cardiac Prosthetic Devices Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 217. Africa Cardiac Prosthetic Devices Market Size, by Transcatheter Procedures, 2017-2032 (USD Million)
TABLE 218. Africa Cardiac Prosthetic Devices Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 219. Africa Cardiac Prosthetic Devices Market Size, by Biological Materials, 2017-2032 (USD Million)
TABLE 220. Africa Cardiac Prosthetic Devices Market Size, by Synthetic Materials, 2017-2032 (USD Million)
TABLE 221. Africa Cardiac Prosthetic Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 222. Africa Cardiac Prosthetic Devices Market Size, by Valvular Heart Diseases, 2017-2032 (USD Million)
TABLE 223. Africa Cardiac Prosthetic Devices Market Size, by Cardiac Arrhythmias, 2017-2032 (USD Million)
TABLE 224. Africa Cardiac Prosthetic Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. Africa Cardiac Prosthetic Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 226. Global Cardiac Prosthetic Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 227. ASEAN Cardiac Prosthetic Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 228. ASEAN Cardiac Prosthetic Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 229. ASEAN Cardiac Prosthetic Devices Market Size, by Left Ventricular Assist Devices, 2017-2032 (USD Million)
TABLE 230. ASEAN Cardiac Prosthetic Devices Market Size, by Pacemakers, 2017-2032 (USD Million)
TABLE 231. ASEAN Cardiac Prosthetic Devices Market Size, by Implantable Pacemakers, 2017-2032 (USD Million)
TABLE 232. ASEAN Cardiac Prosthetic Devices Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 233. ASEAN Cardiac Prosthetic Devices Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 234. ASEAN Cardiac Prosthetic Devices Market Size, by Transcatheter Procedures, 2017-2032 (USD Million)
TABLE 235. ASEAN Cardiac Prosthetic Devices Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 236. ASEAN Cardiac Prosthetic Devices Market Size, by Biological Materials, 2017-2032 (USD Million)
TABLE 237. ASEAN Cardiac Prosthetic Devices Market Size, by Synthetic Materials, 2017-2032 (USD Million)
TABLE 238. ASEAN Cardiac Prosthetic Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 239. ASEAN Cardiac Prosthetic Devices Market Size, by Valvular Heart Diseases, 2017-2032 (USD Million)
TABLE 240. ASEAN Cardiac Prosthetic Devices Market Size, by Cardiac Arrhythmias, 2017-2032 (USD Million)
TABLE 241. ASEAN Cardiac Prosthetic Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. ASEAN Cardiac Prosthetic Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 243. GCC Cardiac Prosthetic Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 244. GCC Cardiac Prosthetic Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. GCC Cardiac Prosthetic Devices Market Size, by Left Ventricular Assist Devices, 2017-2032 (USD Million)
TABLE 246. GCC Cardiac Prosthetic Devices Market Size, by Pacemakers, 2017-2032 (USD Million)
TABLE 247. GCC Cardiac Prosthetic Devices Market Size, by Implantable Pacemakers, 2017-2032 (USD Million)
TABLE 248. GCC Cardiac Prosthetic Devices Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 249. GCC Cardiac Prosthetic Devices Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 250. GCC Cardiac Prosthetic Devices Market Size, by Transcatheter Procedures, 2017-2032 (USD Million)
TABLE 251. GCC Cardiac Prosthetic Devices Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 252. GCC Cardiac Prosthetic Devices Market Size, by Biological Materials, 2017-2032 (USD Million)
TABLE 253. GCC Cardiac Prosthetic Devices Market Size, by Synthetic Materials, 2017-2032 (USD Million)
TABLE 254. GCC Cardiac Prosthetic Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 255. GCC Cardiac Prosthetic Devices Market Size, by Valvular Heart Diseases, 2017-2032 (USD Million)
TABLE 256. GCC Cardiac Prosthetic Devices Market Size, by Cardiac Arrhythmias, 2017-2032 (USD Million)
TABLE 257. GCC Cardiac Prosthetic Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. GCC Cardiac Prosthetic Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 259. European Union Cardiac Prosthetic Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 260. European Union Cardiac Prosthetic Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 261. European Union Cardiac Prosthetic Devices Market Size, by Left Ventricular Assist Devices, 2017-2032 (USD Million)
TABLE 262. European Union Cardiac Prosthetic Devices Market Size, by Pacemakers, 2017-2032 (USD Million)
TABLE 263. European Union Cardiac Prosthetic Devices Market Size, by Implantable Pacemakers, 2017-2032 (USD Million)
TABLE 264. European Union Cardiac Prosthetic Devices Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 265. European Union Cardiac Prosthetic Devices Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 266. European Union Cardiac Prosthetic Devices Market Size, by Transcatheter Procedures, 2017-2032 (USD Million)
TABLE 267. European Union Cardiac Prosthetic Devices Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 268. European Union Cardiac Prosthetic Devices Market Size, by Biological Materials, 2017-2032 (USD Million)
TABLE 269. European Union Cardiac Prosthetic Devices Market Size, by Synthetic Materials, 2017-2032 (USD Million)
TABLE 270. European Union Cardiac Prosthetic Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 271. European Union Cardiac Prosthetic Devices Market Size, by Valvular Heart Diseases, 2017-2032 (USD Million)
TABLE 272. European Union Cardiac Prosthetic Devices Market Size, by Cardiac Arrhythmias, 2017-2032 (USD Million)
TABLE 273. European Union Cardiac Prosthetic Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. European Union Cardiac Prosthetic Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 275. BRICS Cardiac Prosthetic Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 276. BRICS Cardiac Prosthetic Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 277. BRICS Cardiac Prosthetic Devices Market Size, by Left Ventricular Assist Devices, 2017-2032 (USD Million)
TABLE 278. BRICS Cardiac Prosthetic Devices Market Size, by Pacemakers, 2017-2032 (USD Million)
TABLE 279. BRICS Cardiac Prosthetic Devices Market Size, by Implantable Pacemakers, 2017-2032 (USD Million)
TABLE 280. BRICS Cardiac Prosthetic Devices Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 281. BRICS Cardiac Prosthetic Devices Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 282. BRICS Cardiac Prosthetic Devices Market Size, by Transcatheter Procedures, 2017-2032 (USD Million)
TABLE 283. BRICS Cardiac Prosthetic Devices Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 284. BRICS Cardiac Prosthetic Devices Market Size, by Biological Materials, 2017-2032 (USD Million)
TABLE 285. BRICS Cardiac Prosthetic Devices Market Size, by Synthetic Materials, 2017-2032 (USD Million)
TABLE 286. BRICS Cardiac Prosthetic Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 287. BRICS Cardiac Prosthetic Devices Market Size, by Valvular Heart Diseases, 2017-2032 (USD Million)
TABLE 288. BRICS Cardiac Prosthetic Devices Market Size, by Cardiac Arrhythmias, 2017-2032 (USD Million)
TABLE 289. BRICS Cardiac Prosthetic Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. BRICS Cardiac Prosthetic Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 291. G7 Cardiac Prosthetic Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 292. G7 Cardiac Prosthetic Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 293. G7 Cardiac Prosthetic Devices Market Size, by Left Ventricular Assist Devices, 2017-2032 (USD Million)
TABLE 294. G7 Cardiac Prosthetic Devices Market Size, by Pacemakers, 2017-2032 (USD Million)
TABLE 295. G7 Cardiac Prosthetic Devices Market Size, by Implantable Pacemakers, 2017-2032 (USD Million)
TABLE 296. G7 Cardiac Prosthetic Devices Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 297. G7 Cardiac Prosthetic Devices Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 298. G7 Cardiac Prosthetic Devices Market Size, by Transcatheter Procedures, 2017-2032 (USD Million)
TABLE 299. G7 Cardiac Prosthetic Devices Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 300. G7 Cardiac Prosthetic Devices Market Size, by Biological Materials, 2017-2032 (USD Million)
TABLE 301. G7 Cardiac Prosthetic Devices Market Size, by Synthetic Materials, 2017-2032 (USD Million)
TABLE 302. G7 Cardiac Prosthetic Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 303. G7 Cardiac Prosthetic Devices Market Size, by Valvular Heart Diseases, 2017-2032 (USD Million)
TABLE 304. G7 Cardiac Prosthetic Devices Market Size, by Cardiac Arrhythmias, 2017-2032 (USD Million)
TABLE 305. G7 Cardiac Prosthetic Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. G7 Cardiac Prosthetic Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 307. NATO Cardiac Prosthetic Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 308. NATO Cardiac Prosthetic Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 309. NATO Cardiac Prosthetic Devices Market Size, by Left Ventricular Assist Devices, 2017-2032 (USD Million)
TABLE 310. NATO Cardiac Prosthetic Devices Market Size, by Pacemakers, 2017-2032 (USD Million)
TABLE 311. NATO Cardiac Prosthetic Devices Market Size, by Implantable Pacemakers, 2017-2032 (USD Million)
TABLE 312. NATO Cardiac Prosthetic Devices Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 313. NATO Cardiac Prosthetic Devices Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 314. NATO Cardiac Prosthetic Devices Market Size, by Transcatheter Procedures, 2017-2032 (USD Million)
TABLE 315. NATO Cardiac Prosthetic Devices Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 316. NATO Cardiac Prosthetic Devices Market Size, by Biological Materials, 2017-2032 (USD Million)
TABLE 317. NATO Cardiac Prosthetic Devices Market Size, by Synthetic Materials, 2017-2032 (USD Million)
TABLE 318. NATO Cardiac Prosthetic Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 319. NATO Cardiac Prosthetic Devices Market Size, by Valvular Heart Diseases, 2017-2032 (USD Million)
TABLE 320. NATO Cardiac Prosthetic Devices Market Size, by Cardiac Arrhythmias, 2017-2032 (USD Million)
TABLE 321. NATO Cardiac Prosthetic Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. NATO Cardiac Prosthetic Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 323. Global Cardiac Prosthetic Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 324. United States Cardiac Prosthetic Devices Market Size, 2017-2032 (USD Million)
TABLE 325. United States Cardiac Prosthetic Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 326. United States Cardiac Prosthetic Devices Market Size, by Left Ventricular Assist Devices, 2017-2032 (USD Million)
TABLE 327. United States Cardiac Prosthetic Devices Market Size, by Pacemakers, 2017-2032 (USD Million)
TABLE 328. United States Cardiac Prosthetic Devices Market Size, by Implantable Pacemakers, 2017-2032 (USD Million)
TABLE 329. United States Cardiac Prosthetic Devices Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 330. United States Cardiac Prosthetic Devices Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 331. United States Cardiac Prosthetic Devices Market Size, by Transcatheter Procedures, 2017-2032 (USD Million)
TABLE 332. United States Cardiac Prosthetic Devices Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 333. United States Cardiac Prosthetic Devices Market Size, by Biological Materials, 2017-2032 (USD Million)
TABLE 334. United States Car

Companies Mentioned

  • 4C Medical Technologies, Inc.
  • Abbott Laboratories
  • Artivion, Inc.
  • AtriCure, Inc.
  • Berlin Heart GmbH
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Colibri Heart Valve, LLC
  • Corcym S.r.l.
  • Edwards Lifesciences Corporation
  • Getinge AB
  • JenaValve Technology, Inc.
  • Labcor Laboratórios Ltda.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • LivaNova PLC
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Shree Pacetronix Ltd.
  • SynCardia Systems, LLC
  • Terumo Corporation
  • TTK Healthcare Ltd.
  • Venus Medtech (Hangzhou) Inc.
  • W. L. Gore & Associates, Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 13.42 Billion
Forecasted Market Value ( USD ) by 2032 $ 33.24 Billion
Compound Annual Growth Rate16.2%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Cardiac Prosthetic Devices - Global Strategic Business Report - Product Image

Cardiac Prosthetic Devices - Global Strategic Business Report

  • Report
  • 189 Pages
  • Global
From
Cardiac Prosthetic Devices Market Report by Product Type, End-User, and Region 2026-2034 - Product Image

Cardiac Prosthetic Devices Market Report by Product Type, End-User, and Region 2026-2034

  • Report
  • 142 Pages
  • Global
From
Cardiac Prosthetic Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2026 To 2034 - Product Image

Cardiac Prosthetic Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2026 To 2034

  • Report
  • 188 Pages
  • Global
From
Cardiac Prosthetic Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Image

Cardiac Prosthetic Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • 130 Pages
  • Global
From
Cardiac Prosthetic Devices Market Report 2026 - Product Image

Cardiac Prosthetic Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Cardiac Prosthetic Device Market

The Cardiac Prosthetic Device market is a subset of the Cardiovascular Devices market, which includes a range of products used to diagnose, treat, and manage cardiovascular diseases. Cardiac Prosthetic Devices are used to replace or support the function of a damaged or diseased heart. These devices include artificial heart valves, ventricular assist devices, and total artificial hearts. They are designed to improve the quality of life of patients with heart failure, and to reduce the risk of death from cardiovascular diseases. Cardiac Prosthetic Devices are typically implanted surgically, and are powered by batteries or other external power sources. They are designed to be durable and reliable, and to provide long-term support for patients with heart failure. Some of the major companies in the Cardiac Prosthetic Device market include Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, and LivaNova. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.